Medicofarma Biotech SA (WSE:MDB)
Poland · Delayed Price · Currency is PLN 0.2750
+0.0050 (1.85%)
At close: Jul 16, 2025
Medicofarma Biotech Revenue
Medicofarma Biotech had revenue of 112.00K PLN in the quarter ending March 31, 2025, a decrease of -87.16%. This brings the company's revenue in the last twelve months to 464.51K, down -65.81% year-over-year. In the year 2024, Medicofarma Biotech had annual revenue of 1.22M with 63.14% growth.
Revenue (ttm)
464.51K
Revenue Growth
-65.81%
P/S Ratio
40.24
Revenue / Employee
25.81K
Employees
20
Market Cap
18.69M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.22M | 474.05K | 63.14% |
| Dec 31, 2023 | 750.81K | -3.50M | -82.34% |
| Dec 31, 2022 | 4.25M | 915.81K | 27.45% |
| Dec 31, 2021 | 3.34M | -313.69K | -8.59% |
| Dec 31, 2020 | 3.65M | 465.77K | 14.63% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 12.82B |
| Voxel | 556.98M |
| Synektik Spólka Akcyjna | 592.94M |
| Celon Pharma | 215.11M |
| Ryvu Therapeutics | 97.57M |
| Selvita | 359.79M |
| Centrum Medyczne ENEL-MED | 762.83M |
| EMC Instytut Medyczny | 836.81M |